Prognosis and treatment of asymptomatic versus symptomatic metastatic breast cancer: A multicenter retrospective study

Prognosis and treatment of asymptomatic versus symptomatic metastatic breast cancer: A multicenter retrospective study - Prognosis and treatment of asymptomatic versus symptomatic metastatic breast cancer: A multicenter retrospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047149

Enrollment

200

Registered

2022-03-11

Start date

2021-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: metastatic breast cancer

Exclusion criteria

Exclusion criteria: unknown for treatment unknown for symptoms at the diagnosis of metastatic breast cancer

Design outcomes

Primary

Measure	Time frame
overall survival, post-recurrence survival	—

Countries

Japan

Contacts

Public ContactSayaka Kuba

Nagasaki university hospital Surgery

skuba@nagasaki-u.ac.jp0958197316

Outcome results